GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 94 filers reported holding GOSSAMER BIO INC in Q4 2019. The put-call ratio across all filers is 13.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,834 | -69.8% | 3,404 | -56.4% | 0.00% | – |
Q2 2023 | $9,370 | +8575.9% | 7,809 | -90.9% | 0.00% | – |
Q1 2023 | $108 | -40.7% | 85,361 | +1.6% | 0.00% | – |
Q4 2022 | $182 | -100.0% | 84,017 | +2.5% | 0.00% | -100.0% |
Q3 2022 | $982,000 | +59.4% | 81,933 | +11.2% | 0.00% | 0.0% |
Q2 2022 | $616,000 | -16.4% | 73,650 | -13.3% | 0.00% | 0.0% |
Q1 2022 | $737,000 | -28.6% | 84,960 | -6.9% | 0.00% | 0.0% |
Q4 2021 | $1,032,000 | -9.3% | 91,264 | +0.8% | 0.00% | -50.0% |
Q3 2021 | $1,138,000 | +60.5% | 90,547 | +3.7% | 0.00% | +100.0% |
Q2 2021 | $709,000 | -2.1% | 87,324 | +11.6% | 0.00% | 0.0% |
Q1 2021 | $724,000 | -9.0% | 78,268 | -4.9% | 0.00% | 0.0% |
Q4 2020 | $796,000 | -11.3% | 82,308 | +13.8% | 0.00% | 0.0% |
Q3 2020 | $897,000 | -11.6% | 72,300 | -7.4% | 0.00% | -50.0% |
Q2 2020 | $1,015,000 | +65.8% | 78,095 | +29.5% | 0.00% | +100.0% |
Q1 2020 | $612,000 | -31.6% | 60,309 | +5.3% | 0.00% | 0.0% |
Q4 2019 | $895,000 | -3.1% | 57,279 | +4.1% | 0.00% | -50.0% |
Q3 2019 | $924,000 | +76.7% | 55,013 | +133.5% | 0.00% | +100.0% |
Q2 2019 | $523,000 | +93.0% | 23,560 | +88.3% | 0.00% | 0.0% |
Q1 2019 | $271,000 | – | 12,514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |